Health Care Equipment Supplier CytoSorbents Shares Dip Despite Projected Revenue Growth
CytoSorbents CEO Phillip Chan said the company is preparing to enter the North American market with DrugSorb-ATR to reduce the severity of perioperative bleeding in CABG surgery due to Brilinta, ...
manilatimes9h
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...
Results for "a ba yt 2n1"
Hyundai and Kia EVs now available with the $7,500 tax credit Tesla's Cybertruck now qualifies for the $7,500 tax credit in the US Tesla deliveries report is out: well short of yearly target ...